Devices › Coronavirus antigen detection test system.
Device brand name · Not classified
Bd Veritor At-Home Covid-19 Test: medical device reports filed with FDA
276 reports name it, 2021–2023. Manufacturer given most often on reports: Becton Dickinson & Sparks. Product code QKP.
- 276
- device reports naming the brand
- 0% of all MAUDE reports · about 59 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 97.8%
- classified as malfunction
- 98.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 276 reports that name the brand "Bd Veritor At-Home Covid-19 Test" (not classified), received between November 2021 and September 2023; the manufacturer given most often on reports is Becton Dickinson & Sparks. Spellings of one product vary from report to report.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (97.8%) and injury (2.2%); across all coronavirus antigen detection test system. reports (product code QKP) death is recorded in 0% and malfunction in 98.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are incorrect, inadequate or imprecise result or readings (39.1%), false negative result (21.7%) and false positive result (19.2%). The patient problems coded most often are appropriate clinical signs, symptoms and conditions term/code not available, chemical exposure and hypersensitivity/allergic reaction. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 26,765 reports carrying product code QKP. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Incorrect, inadequate or imprecise result or readings | 108 | 39.1% | 8.8% |
| False negative result | 60 | 21.7% | 21.2% |
| False positive result | 53 | 19.2% | 53.2% |
| Non reproducible results | 35 | 12.7% | 1.7% |
| Device markings/labelling problema problem with the device markings or label | 4 | 1.4% | 0.2% |
| Improper or incorrect procedure or method | 3 | 1.1% | 0.5% |
| Leak/splashthe device leaked | 3 | 1.1% | 0% |
| Missing information | 2 | 0.7% | 0% |
| Incorrect measurementthe device measured wrongly | 1 | 0.4% | 0% |
| Patient data problem | 1 | 0.4% | 0% |
| Product quality problem | 1 | 0.4% | 0.3% |
| Unauthorized access to computer system | 1 | 0.4% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Appropriate clinical signs, symptoms and conditions term/code not available | 1 | 0.4% |
| Chemical exposure | 1 | 0.4% |
| Hypersensitivity/allergic reaction | 1 | 0.4% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Bd Veritor At-Home Covid-19 Test | Product code QKP | All MAUDE reports |
|---|---|---|---|
| Reports | 276 | 26,765 | 26,136,888 |
| Share of that pool | — | 1% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 2.2% | 1.7% | 36.2% |
| Classified as malfunction | 97.8% | 98.1% | 62.3% |
| Filed by the manufacturer | 99.6% | 94.9% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code QKP
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Quickvue At-Home Otc Covid-19 Test | 4,714 | 30 | 0% |
| Sofia Sars Antigen Fia Ns Swab | 3,865 | 2 | 0% |
| Ellume Covid-19 Home Test | 2,999 | 0 | 0% |
| Lumiradx Sars-Cov-2 Ag Test Strip Kit | 2,150 | 0 | 0% |
| Binaxnow Covid-19 Ag Card | 2,076 | 0 | 0% |
| Bd Rapid Detection Of Sars-Cov-2 Veritor | 1,581 | 0 | 0% |
| Flowflex COVID-19 Antigen Home Test | 1,312 | 172 | 0% |
| Binaxnow Covid-19 Ag Self Test 2ct | 1,298 | 53 | 0.1% |
| Quickvue Sars Antigen Test | 785 | 0 | 0% |
| Binaxnow Covid-19 Antigen Self Test | 625 | 0 | 0% |
| Bd Rapid Detection Of Sars-Cov-2 Veritor Assay | 520 | 0 | 0% |
| Binaxnow Covid-19 Antigen Self-Test | 487 | 0 | 0% |
| Ellume Covid-19 Home Test Kit | 470 | 0 | 0% |
| Binax Now Covid-19 Ag Card | 422 | 0 | 0% |
| Ihealth | 362 | 13 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Bd Veritor At-Home Covid-19 Test reports
How many FDA reports name Bd Veritor At-Home Covid-19 Test?
276 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (97.8%) and injury (2.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
incorrect, inadequate or imprecise result or readings (39.1%), false negative result (21.7%), false positive result (19.2%), non reproducible results (12.7%) and device markings/labelling problem (1.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.6%) and voluntary reports (0.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Bd Veritor At-Home Covid-19 Test was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.